Maximizing compliance and efficacy in the use of 5-ASA formulations for ulcerative colitis: Commentary

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)12-13
Number of pages2
JournalGastroenterology and Hepatology
Volume3
Issue number8 SUPPL. 25
StatePublished - Aug 2007

Fingerprint

Ulcerative Colitis
Compliance

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Maximizing compliance and efficacy in the use of 5-ASA formulations for ulcerative colitis : Commentary. / Loftus, Jr, Edward Vincent.

In: Gastroenterology and Hepatology, Vol. 3, No. 8 SUPPL. 25, 08.2007, p. 12-13.

Research output: Contribution to journalComment/debate

@article{344164961d2a492fabd096d2f2f66d22,
title = "Maximizing compliance and efficacy in the use of 5-ASA formulations for ulcerative colitis: Commentary",
author = "{Loftus, Jr}, {Edward Vincent}",
year = "2007",
month = "8",
language = "English (US)",
volume = "3",
pages = "12--13",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "8 SUPPL. 25",

}

TY - JOUR

T1 - Maximizing compliance and efficacy in the use of 5-ASA formulations for ulcerative colitis

T2 - Commentary

AU - Loftus, Jr, Edward Vincent

PY - 2007/8

Y1 - 2007/8

UR - http://www.scopus.com/inward/record.url?scp=34648846211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648846211&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:34648846211

VL - 3

SP - 12

EP - 13

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 8 SUPPL. 25

ER -